Search research articles
Contact Us
Filters
Showing results (111-120 of 304) with videos related to
Page
of 31
Sort By:
Dementia and Geriatric Cognitive Disorders
|
January 8, 2005
Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies
Brit Mollenhauer, Lukas Cepek, Mirko Bibl, et al.
Brain : a Journal of Neurology
|
April 8, 2006
CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
Mirko Bibl, Brit Mollenhauer, Hermann Esselmann, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
October 9, 2018
Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease
Niels Kruse, Amanda Heslegrave, Vandana Gupta, et al.
Biomarkers in Medicine
|
August 29, 2015
The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
Anja Hviid Simonsen, Bea Kuiperij, Omar Mukhtar Ali El-Agnaf, et al.
Neuro-Degenerative Diseases
|
July 12, 2007
Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies
Brit Mollenhauer, Petra Steinacker, Erik Bahn, et al.
Journal of Neurochemistry
|
October 11, 2015
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders
Brit Mollenhauer, Lucilla Parnetti, Irena Rektorova, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 7, 2021
Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders
Isabel Schulz, Niels Kruse, Roland G Gera, et al.
Molecular Neurobiology
|
December 16, 2016
Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt-Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress
Waqas Tahir, Saima Zafar, Franc Llorens, et al.
Neurogenetics
|
June 19, 2012
Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson's disease
Eva C Schulte, Brit Mollenhauer, Alexander Zimprich, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 11, 2016
Validation of conversion between mini-mental state examination and montreal cognitive assessment
Michael Lawton, Meike Kasten, Margaret T May, et al.
Page
of 31
Search research articles
Search
Showing results (111-120 of 304) with videos related to
Sort By:
Page
of 31
Dementia and Geriatric Cognitive Disorders
|
January 8, 2005
Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies
Brit Mollenhauer, Lukas Cepek, Mirko Bibl, et al.
Brain : a Journal of Neurology
|
April 8, 2006
CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
Mirko Bibl, Brit Mollenhauer, Hermann Esselmann, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
October 9, 2018
Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease
Niels Kruse, Amanda Heslegrave, Vandana Gupta, et al.
Biomarkers in Medicine
|
August 29, 2015
The utility of α-synuclein as biofluid marker in neurodegenerative diseases: a systematic review of the literature
Anja Hviid Simonsen, Bea Kuiperij, Omar Mukhtar Ali El-Agnaf, et al.
Neuro-Degenerative Diseases
|
July 12, 2007
Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies
Brit Mollenhauer, Petra Steinacker, Erik Bahn, et al.
Journal of Neurochemistry
|
October 11, 2015
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders
Brit Mollenhauer, Lucilla Parnetti, Irena Rektorova, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 7, 2021
Systematic Assessment of 10 Biomarker Candidates Focusing on α-Synuclein-Related Disorders
Isabel Schulz, Niels Kruse, Roland G Gera, et al.
Molecular Neurobiology
|
December 16, 2016
Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt-Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress
Waqas Tahir, Saima Zafar, Franc Llorens, et al.
Neurogenetics
|
June 19, 2012
Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson's disease
Eva C Schulte, Brit Mollenhauer, Alexander Zimprich, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
February 11, 2016
Validation of conversion between mini-mental state examination and montreal cognitive assessment
Michael Lawton, Meike Kasten, Margaret T May, et al.
Page
of 31